Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diffusion MRI Changes in Response to Tysabri in Multiple Sclerosis
2014-003209-14Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of natalizumab in multiple sclerosis (MS), sponsored by Strasbourg University Hospital. Primary endpoint: Primary: Change in fractional anisotropy on diffusion MRI over 2 years. Started Jun 2015; status: completed.
02
Drugs
natalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2014-003209-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003209-14.